Selexis Corporate Overview Q3 2017
September 29, 2017
Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell-line generation, providing unparalleled proprietary technology and the highly specialized expertise necessary to translate scientific innovation into life-saving medicines for patients.
Learn More
Selexis Customer Survey Q2 2017
August 4, 2017
In 2017, Selexis  surveyed our partners to collect feedback and gain insight about our company and technology. With our partners’ insights, we can build upon our business, continue to advance our technology and enhance our overall partner experience.
Learn More
JSR Life Sciences, KBI Biopharma, Selexis Overview
June 21, 2017
The Contract Development Manufacturing Organization of the 21st Century Combined Forces to Serve as the Biopharmaceutical Customer- and Patient-Focused CDMO with the Most Robust and Fastest “Gene to GMP” Service Offering in the Industry
Learn More